Iovance Biotherapeutics: Q1 Earnings Snapshot

Published: 2026-05-07 07:13:09 ET IOVA

Published on 05/07/2026 at 07:13 am EDT

SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $79 million in its first quarter.

On a per-share basis, the San Carlos, California-based company said it had a loss of 19 cents.

The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 19 cents per share.

The biotechnology company posted revenue of $71.4 million in the period.

For the current quarter ending in June, Iovance Biotherapeutics said it expects revenue in the range of $86 million to $88 million.

The company expects full-year revenue in the range of $350 million to $370 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News